Roth, Arnaud D <br/><br/>
Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer.  [electronic resource] 

 -  Journal of the National Cancer Institute  Nov 2012 
 - 1635-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2105 
<br/><br/><label>Standard No.: </label>10.1093/jnci/djs427  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--genetics<br/>Camptothecin--administration & dosage<br/>Chemotherapy, Adjuvant<br/>Chromosomes, Human, Pair 18--genetics<br/>Colonic Neoplasms--drug therapy<br/>Drug Administration Schedule<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Immunohistochemistry<br/>Irinotecan<br/>Kaplan-Meier Estimate<br/>Leucovorin--administration & dosage<br/>Loss of Heterozygosity<br/>Male<br/>Microsatellite Instability<br/>Middle Aged<br/>Multivariate Analysis<br/>Mutation<br/>Neoplasm Staging<br/>Predictive Value of Tests<br/>Prognosis<br/>Proportional Hazards Models<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Proto-Oncogene Proteins p21(ras)<br/>Research Design<br/>Smad4 Protein--metabolism<br/>ras Proteins--genetics